Quebec Court Strikes Down Parts of Federal Anti-Cloning Law
By The Canadian Press,
The Canadian Press
| 06. 25. 2008
MONTREAL - The Quebec Court of Appeal has ruled that Ottawa overstepped its authority when drawing up laws on assisted human reproduction.
The court says dozens of federal provisions on clinical and research activities are unconstitutional because they encroach on provincial jurisdictions.
Appellate court justices determined that assisted reproduction should be considered a health matter as opposed to a criminal justice issue regulated by Parliament.
The Quebec government had asked the appeals court to review the 2004 federal law on assisted human reproduction, believing parts of it should be under its control.
In a 53-page judgment, the court agreed by ruling that 22 articles of the law interfered with provincial powers.
Ottawa's assisted human reproduction law bans human cloning and the buying and selling of human embryos.
Related Articles
By Judd Boaz and Elise Kinsella, ABC News | 03.17.2026
By Gabriele Pichlhofer and Tino Plümecke, Guest Contributors
| 03.25.2026
A German translation of this interview will be published in May 2026 in the German GID MAGAZIN, which focuses on the market for reproductive technologies. For more information, visit: Gen-ethisches Netzwerk
Egg donation is currently prohibited in Germany and Switzerland, but both countries have been debating its legalization for years. In Switzerland, a legal framework is currently being developed, with a first draft expected by the end of the year. Yet the debate rarely draws on scientific evidence. Instead...
By Charles Pulliam-Moore, The Verge | 03.21.2026
Like many people, director Valerie Veatch was intrigued when OpenAI first released its Sora text-to-video generative AI model to the public in 2024. Though she didn’t fully understand the technology, she was curious about what it could do, and she...
By Ritsuko Kawai, Wired | 03.14.2026
On March 6, Japan’s Ministry of Health, Labor and Welfare officially granted conditional and time-limited marketing authorization to two regenerative medical products derived from reprogrammed iPS cells, marking exactly 20 years since the creation of mouse iPS cells.These will...
